- Home
- SIDU vs ENSC Comparison
SIDU vs ENSC Comparison
Compare SIDU & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIDU
- ENSC
- Stock Information
- Founded
- SIDU 2012
- ENSC 2003
- Country
- SIDU United States
- ENSC United States
- Employees
- SIDU N/A
- ENSC N/A
- Industry
- SIDU Telecommunications Equipment
- ENSC Biotechnology: Pharmaceutical Preparations
- Sector
- SIDU Telecommunications
- ENSC Health Care
- Exchange
- SIDU Nasdaq
- ENSC Nasdaq
- Market Cap
- SIDU 39.8M
- ENSC 9.0M
- IPO Year
- SIDU 2021
- ENSC N/A
- Fundamental
- Price
- SIDU $2.53
- ENSC $6.45
- Analyst Decision
- SIDU Strong Buy
- ENSC
- Analyst Count
- SIDU 1
- ENSC 0
- Target Price
- SIDU $10.00
- ENSC N/A
- AVG Volume (30 Days)
- SIDU 2.2M
- ENSC 63.3K
- Earning Date
- SIDU 03-25-2025
- ENSC 03-14-2025
- Dividend Yield
- SIDU N/A
- ENSC N/A
- EPS Growth
- SIDU N/A
- ENSC N/A
- EPS
- SIDU N/A
- ENSC N/A
- Revenue
- SIDU $5,189,912.00
- ENSC $4,421,404.00
- Revenue This Year
- SIDU $36.85
- ENSC $89.78
- Revenue Next Year
- SIDU $40.00
- ENSC N/A
- P/E Ratio
- SIDU N/A
- ENSC N/A
- Revenue Growth
- SIDU N/A
- ENSC 40.41
- 52 Week Low
- SIDU $1.15
- ENSC $2.12
- 52 Week High
- SIDU $10.15
- ENSC $22.47
- Technical
- Relative Strength Index (RSI)
- SIDU 42.65
- ENSC 39.92
- Support Level
- SIDU $2.37
- ENSC $6.61
- Resistance Level
- SIDU $2.54
- ENSC $7.36
- Average True Range (ATR)
- SIDU 0.28
- ENSC 0.65
- MACD
- SIDU -0.06
- ENSC -0.13
- Stochastic Oscillator
- SIDU 14.52
- ENSC 6.32
About SIDU Sidus Space Inc.
Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.